Literature DB >> 32442495

The burden of disease in Saudi Arabia 1990-2017: results from the Global Burden of Disease Study 2017.

.   

Abstract

BACKGROUND: Availability of data to assess the population health and provision and quality of health care in Saudi Arabia has been lacking. In 2010, Saudi Arabia began a major investment and transformation programme in the health-care sector. Here we assess the impact of this investment era on mortality, health loss, risk factors, and health-care services in the country.
METHODS: We used results of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 to describe the levels and temporal patterns in deaths, health loss, risk factors, and health-care access and quality in the Saudi Arabian population during 1990-2010 (before the health-care investments and reform) and 2010-17 (during health-care investments and reform). We also compared patterns in health outcomes between these periods with those in the north Africa and the Middle East GBD region and the Gulf Cooperation Council countries.
FINDINGS: Age-standardised mortality in Saudi Arabia decreased from 1990 to 2010 (annualised rate of change of -0·58%), and this decrease was further accelerated from 2010 to 2017 (-2·20%). The north Africa and the Middle East GBD region also had decreases in mortality during these periods, but for 2010-17 the decrease was not as low as in Saudi Arabia (-1·29%). Transport injuries decreased from third ranked cause of disability-adjusted life-years in 2010 to fifth ranked cause in 2017 in Saudi Arabia, below cardiovascular diseases (ranked first) and musculoskeletal disorders (ranked second). Years lived with disability (YLDs) due to mental disorders, substance use disorders, neoplasms, and neurological disorders consistently increased over the periods 1990-2010 and 2010-17. Between 1990 and 2017, attributable YLDs due to metabolic, behavioural, and environmental or occupational risk factors remained almost unchanged in Saudi Arabia, with high body-mass index, high fasting plasma glucose concentration, and drug use increasing across all age groups. Health-care Access and Quality (HAQ) Index levels increased in Saudi Arabia during this period with similar patterns to the rest of the Gulf Cooperation Council countries and the north Africa and the Middle East GBD region.
INTERPRETATION: Decreases in mortality continued at greater rates in Saudi Arabia during the period of 2010-17 than in 1990-2010. HAQ Index levels have also improved. Public health policy makers in Saudi Arabia need to increase efforts to address preventable risk factors that are major contributors to the burden of ill health and disability. FUNDING: Bill & Melinda Gates Foundation.
Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Year:  2020        PMID: 32442495     DOI: 10.1016/S2542-5196(20)30075-9

Source DB:  PubMed          Journal:  Lancet Planet Health        ISSN: 2542-5196


  29 in total

1.  Prospects of Integrating Gig Economy in the Saudi Arabian Health-care System from the Perspectives of Health-care Decision-makers and Practitioners.

Authors:  Turki Alanzi
Journal:  J Healthc Leadersh       Date:  2021-10-15

2.  An Assessment of the Knowledge and Practices of Adults in Jazan, Saudi Arabia, Concerning Routine Medical Checkups.

Authors:  Ibrahim M Gosadi; Raum A Ayoub; Hakemah T Albrahim; Manar S Alhakami; Eilaf H Ageely; Rawiyah S Alwadani; Halah M Shayani; Salma A Shteafi
Journal:  Patient Prefer Adherence       Date:  2022-08-05       Impact factor: 2.314

3.  Health Research Priority Agenda for Ministry of Health, Kingdom of Saudi Arabia from 2020 to 2025.

Authors:  Athari Alotaibi; Wafaa Saleh; Abdulaziz Abdulbaqi; Maha Alosaimi
Journal:  J Epidemiol Glob Health       Date:  2022-10-04

4.  Association of blood lipids with coronary artery plaque among Saudi patients referred to computed tomography.

Authors:  Sumaya Al Helali; Muhammad Abid Hanif; Ahmad Al Majed; Nura Alshugair; Abdullah Belfageih; Hamad Al Qahtani; Sameer Al Dulikan
Journal:  BMC Cardiovasc Disord       Date:  2022-06-03       Impact factor: 2.174

5.  Predictors of Mortality in Patients with Chronic Heart Failure: Is Hyponatremia a Useful Clinical Biomarker?

Authors:  Manal M Alem
Journal:  Int J Gen Med       Date:  2020-07-20

6.  Cardiovascular disease risk prevention services by pharmacists in Saudi Arabia: what do policymakers and opinion leaders think?

Authors:  Hadi A Almansour; Nouf M Aloudah; Tariq M Alhawassi; Betty Chaar; Ines Krass; Bandana Saini
Journal:  J Pharm Policy Pract       Date:  2021-05-06

7.  Focused Cardiac Ultrasound is Applicable to Internal Medicine and Critical Care but Skill Gaps Currently Limit Use.

Authors:  Naveed Mahmood; Mamdouh Souleymane; Rajkumar Rajendram; Amro M T Ghazi; Mubashar Kharal; Mohammad AlQahtani
Journal:  J Saudi Heart Assoc       Date:  2020-11-09

8.  Clinical, Echocardiographic, and Therapeutic Characteristics of Heart Failure in Patients with Preserved, Mid-Range, and Reduced Ejection Fraction: Future Directions.

Authors:  Manal M Alem
Journal:  Int J Gen Med       Date:  2021-02-16

9.  Upper gastrointestinal bleeding: Causes and patient outcomes.

Authors:  Majid A Almadi; Abdulelah Almutairdi; Ibrahim M Alruzug; Thamer A Aldarsouny; Toufic Semaan; Manhal K Aldaher; Adnan AlMustafa; Nahla Azzam; Faisal Batwa; Badr Albawardy; Abdulrahman Aljebreen
Journal:  Saudi J Gastroenterol       Date:  2021 Jan-Feb       Impact factor: 2.485

10.  Students academic and social concerns during COVID-19 pandemic.

Authors:  Azzah Al-Maskari; Thurayya Al-Riyami; Siraj K Kunjumuhammed
Journal:  Educ Inf Technol (Dordr)       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.